Alba Toll

609 total citations
29 papers, 246 citations indexed

About

Alba Toll is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Alba Toll has authored 29 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 8 papers in Clinical Psychology and 6 papers in Pharmacology. Recurrent topics in Alba Toll's work include Schizophrenia research and treatment (11 papers), Bipolar Disorder and Treatment (10 papers) and Tryptophan and brain disorders (4 papers). Alba Toll is often cited by papers focused on Schizophrenia research and treatment (11 papers), Bipolar Disorder and Treatment (10 papers) and Tryptophan and brain disorders (4 papers). Alba Toll collaborates with scholars based in Spain, United Kingdom and United States. Alba Toll's co-authors include Víctor Pérez, Anna Mané, Daniel Bergé, Laura Díaz, Miquel Bernardo, Rosa Ayesa‐Arriola, Emilio Fernández-Egea, Esther Setién‐Suero, Benedicto Crespo‐Facorro and Gisela Mezquida and has published in prestigious journals such as Psychological Medicine, Journal of Affective Disorders and Psychoneuroendocrinology.

In The Last Decade

Alba Toll

27 papers receiving 244 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alba Toll Spain 8 128 70 63 50 36 29 246
Thomas Charpeaud France 8 82 0.6× 44 0.6× 52 0.8× 37 0.7× 27 0.8× 20 197
N. Del Cacho Spain 10 138 1.1× 67 1.0× 41 0.7× 33 0.7× 11 0.3× 23 225
Keane Lim Singapore 7 121 0.9× 47 0.7× 86 1.4× 28 0.6× 22 0.6× 15 255
Mehak Pahwa United States 8 144 1.1× 41 0.6× 81 1.3× 46 0.9× 28 0.8× 15 272
Dorte Nordholm Denmark 10 153 1.2× 56 0.8× 33 0.5× 53 1.1× 15 0.4× 16 277
Christian Núñez Spain 12 151 1.2× 31 0.4× 75 1.2× 32 0.6× 20 0.6× 30 355
María Juncal‐Ruíz Spain 11 196 1.5× 48 0.7× 26 0.4× 67 1.3× 15 0.4× 22 288
Yuen Mei See Singapore 8 192 1.5× 42 0.6× 102 1.6× 52 1.0× 47 1.3× 17 369
Mercedes Zumárraga Spain 12 154 1.2× 52 0.7× 25 0.4× 68 1.4× 64 1.8× 33 345
Matteo Lazzaretti Italy 11 131 1.0× 150 2.1× 65 1.0× 13 0.3× 50 1.4× 21 373

Countries citing papers authored by Alba Toll

Since Specialization
Citations

This map shows the geographic impact of Alba Toll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alba Toll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alba Toll more than expected).

Fields of papers citing papers by Alba Toll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alba Toll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alba Toll. The network helps show where Alba Toll may publish in the future.

Co-authorship network of co-authors of Alba Toll

This figure shows the co-authorship network connecting the top 25 collaborators of Alba Toll. A scholar is included among the top collaborators of Alba Toll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alba Toll. Alba Toll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toll, Alba, et al.. (2024). Clozapine use in the first two years after first-episode psychosis in a real-world clinical sample. PubMed. 18(2). 125–132. 1 indexed citations
2.
Toll, Alba, et al.. (2023). Relationship between thyroid-stimulating hormone, BDNF levels, and hippocampal volume in antipsychotic-naïve first-episode psychosis patients. Frontiers in Psychiatry. 14. 1301714–1301714. 6 indexed citations
3.
Toll, Alba, Laura Blanco‐Hinojo, Daniel Bergé, et al.. (2023). Higher lymphocyte count associated with larger hippocampal volume and fewer depressive symptoms in drug–na ïve first-episode psychosis. European Neuropsychopharmacology. 69. 47–55. 3 indexed citations
4.
Álvarez, Pilar, Beatríz Bellosillo, Francesc Colom, et al.. (2023). Y-chromosome in the olfactory neuroepithelium as a potential biomarker of depression in women with male offspring: an exploratory study. Molecular and Cellular Biochemistry. 479(6). 1451–1455. 1 indexed citations
5.
Toll, Alba, et al.. (2023). Factors associated with suicide attempts in first-episode psychosis during the first two years after onset. Psychiatry Research. 325. 115232–115232. 10 indexed citations
6.
Torre‐Luque, Alejandro de la, Neus Salvat‐Pujol, Aida de Arriba‐Arnau, et al.. (2022). Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 121. 110674–110674. 13 indexed citations
7.
Mezquida, Gisela, Patricia Gassó, Natàlia Rodríguez, et al.. (2022). Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode. Psychological Medicine. 53(10). 4634–4647. 7 indexed citations
8.
Amoretti, Sílvia, Norma Verdolini, Ana M. Sánchez-Torres, et al.. (2022). Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: differences between males and females. Frontiers in Psychiatry. 13. 982583–982583. 2 indexed citations
9.
Torre‐Luque, Alejandro de la, Marı́a J. Portella, Neus Salvat‐Pujol, et al.. (2021). Relationship between immunometabolic status and cognitive performance among major depression disorder patients. Psychoneuroendocrinology. 137. 105631–105631. 2 indexed citations
10.
Moreno‐Poyato, Antonio R., et al.. (2021). Determinants of mechanical restraint in an acute psychiatric care unit. World Journal of Psychiatry. 11(10). 854–863. 7 indexed citations
11.
González-Blanco, Leticia, María Paz García‐Portilla, Miguel Gutiérrez, et al.. (2021). Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis. Schizophrenia Research. 236. 19–28. 7 indexed citations
12.
Pérez, Víctor, Adrián Pérez‐Aranda, Francesc Colom, et al.. (2020). A multicenter, observational study of pain and functional impairment in individuals with major depressive disorder in partial remission: the DESIRE study. Journal of Affective Disorders. 281. 657–660. 4 indexed citations
13.
Toll, Alba, Daniel Bergé, Keith Burling, et al.. (2020). Cannabis use influence on peripheral brain-derived neurotrophic factor levels in antipsychotic-naïve first-episode psychosis. European Archives of Psychiatry and Clinical Neuroscience. 270(7). 851–858. 7 indexed citations
14.
Portella, Marı́a J., Neus Salvat‐Pujol, Aida de Arriba‐Arnau, et al.. (2020). Age at illness onset and physical activity are associated with cognitive impairment in patients with current diagnosis of major depressive disorder. Journal of Affective Disorders. 279. 343–352. 15 indexed citations
15.
Pérez, Víctor, Matilde Elices, Alba Toll, et al.. (2020). The Suicide Prevention and Intervention Study (SURVIVE): Study protocol for a multisite cohort study with nested randomized-controlled trials. PubMed. 16(1). 16–23. 5 indexed citations
16.
Setién‐Suero, Esther, et al.. (2017). Targeting recovery in first episode psychosis: The importance of neurocognition and premorbid adjustment in a 3-year longitudinal study. Schizophrenia Research. 195. 320–326. 20 indexed citations
17.
Mezquida, Gisela, George Savulich, Clemente García‐Rizo, et al.. (2017). Inverse association between negative symptoms and body mass index in chronic schizophrenia. Schizophrenia Research. 192. 69–74. 21 indexed citations
18.
Toll, Alba. (2015). Brain-derived neurotrophic factor levels in first episode of psychosis: A systematic review. World Journal of Psychiatry. 5(1). 154–154. 37 indexed citations
19.
Mané, Anna, et al.. (2015). Relationship between cannabis and psychosis: Reasons for use and associated clinical variables. Psychiatry Research. 229(1-2). 70–74. 43 indexed citations
20.
Fugl-Meyer, Kerstin, Diane R. Stothard, Mark Belger, et al.. (2006). The effect of tadalafil on psychosocial outcomes in Swedish men with erectile distress: a multicentre, non-randomised, open-label clinical study. International Journal of Clinical Practice. 60(11). 1386–1393. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026